Related Experiment Video

Updated: Aug 11, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis

Hyun Jung Oh1, Kyung-Kwon Lee, Su Jung Song

  • 1Department of Biological Sciences, Biomedical Research Center, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.

Cancer Research
|March 3, 2006
PubMed

Insights

The tumor suppressor RASSF1A promotes Mst1 activation and apoptosis signaling. RASSF1A facilitates Mst1 activation, enhancing apoptosis induced by death receptor pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Apoptosis Signaling

Background:

  • Mammalian sterile 20-like kinase 1 (Mst1) is crucial in apoptosis, activated by cleavage or phosphorylation during apoptotic stimuli like Fas ligation.
  • The tumor suppressor RASSF1A's role in Mst1 activation and death receptor-mediated apoptosis is not fully understood.

Purpose of the Study:

  • To investigate the role of RASSF1A in Mst1 activation and Mst1-mediated apoptosis.
  • To elucidate the interaction between RASSF1A and Mst1 in death receptor signaling pathways.

Main Methods:

  • Immunoprecipitation and immunofluorescence to analyze Mst1-RASSF1A association and localization.
  • RNA interference (RNAi) to deplete RASSF1A and assess Mst1 activation and apoptosis.
  • Recombinant protein assays to study Mst1 kinase activity in vitro and in cells.
  • Functional assays involving RASSF1A-deficient cells and Mst1 depletion.

Main Results:

  • Mst1 and RASSF1A were found to associate and colocalize on microtubules in mammalian cells.
  • Recombinant RASSF1A inhibited Mst1 kinase activity in vitro, but RASSF1A overexpression enhanced Mst1 activity in cells.
  • RASSF1A depletion reduced Mst1 activation and Fas-induced apoptosis, while RASSF1A restoration increased them.
  • Depletion of Mst1 inhibited the pro-apoptotic effect of RASSF1A overexpression in Fas-induced apoptosis.

Conclusions:

  • RASSF1A plays a significant role in facilitating Mst1 activation.
  • RASSF1A promotes apoptosis induced by death receptor signaling, partly through Mst1 activation.
  • The interaction between RASSF1A and Mst1 is critical for regulating apoptosis in response to death receptor stimuli.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...